Patent · US Active

Methods for modulating ATRX-dependent gene repression

US10858650B2 · kind B2 · utility

0Cited by
64References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2015
Grant dateDec 8, 2020
Priority date—
Expiry dateJan 19, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for modulation of the activity of alpha thalassemia/mental retardation syndrome X-linked (ATRX), e.g., modulation of DNA-ATRX or RNA-ATRX interactions, and methods for identifying and using compounds that modulate DNA-ATRX or RNA-ATRX interactions, as well as the compounds themselves.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.